|« Previous month||Next month »|
29-Nov-2012 - The industry group that prompted the USP to delay new elemental impurities standards says even when completed, ICH Q3D will take time to implement.
29-Nov-2012 - Belgian biopharmaceutical company UCB has agreed to sell its manufacturing plant in Vapi, India to API maker Exemed Pharmaceuticals.
29-Nov-2012 - The group behind the excipient certification scheme Excipact will train SGS and blue inspection body GmbH auditors under agreements signed this week.
28-Nov-2012 - The US Federal Trade Commission (FTC) says making insignificant reformulations to drugs to block generic competition violates antitrust laws.
28-Nov-2012 - Hovione and Solvias have become the latest suppliers to team on drug solubility and bioavailability services in a new deal announced today.
28-Nov-2012 - in-PharmaTechnologist.com presents its latest round-up of movers and shakers in the world of pharmaceuticals, including news from Cipla, Dr. Reddy’s and Immunogen.
27-Nov-2012 - Pfizer is re-jigging its failed virtual trial model and could re-launch the programme as soon as 2013.
27-Nov-2012 - The bioavailability market lacks a leader that can offer comprehensive solutions according to Merck Millipore, which has set its sights on filling the gap through investments and a new lab....
27-Nov-2012 - "Church brand Chihpen Tianyun capsule”,“wind pain Kang membrane ball” and “brain Xuesaitong pill” are just three of the ‘drug’ products named and shamed by China’s SFDA in a clampdown on...
27-Nov-2012 - The USP has delayed new elemental impurities standards but is still confident they can be harmonized with ICH Q3D even if May 2014 implementation target is kept.
27-Nov-2012 - Rhenovia Pharma says the multi-drug delivery capabilities of its transdermal-patch could have wider application.
26-Nov-2012 - BASF’s ever-expanding nutrition unit says its €644m bid last week bid for Norwegian omega-3 firm, Pronova Biopharma, is as important for its food supplements business as its pharmaceutical operations.
26-Nov-2012 - APIs made in Switzerland won’t need ‘written confirmation’ of quality after the EC deemed the country's manufacturing standards meet its requirements.
26-Nov-2012 - Indian Plans to hand quality oversight of APIs shipped to Europe to ‘competent authority’ are still being discussed according to Pharmexcil.
26-Nov-2012 - Euticals Limited has halted API production at its Welsh site after local authorities found it was housing “substantial” quantities of a potentially explosive chemical.
22-Nov-2012 - The US FDA wants IRBs to remember it is their responsibility to check investigator qualifications, make sure sites are up to code and say if an IND is necessary for...
22-Nov-2012 - in-Pharmatechnologist.com is in Mumbai this week for CPhI India to report news from BASF, Dow Wolff Cellulosics and Bend Research.
22-Nov-2012 - The European Commission (EC) has asked the industry how long it will take to change labels of drugs marked for additional post-market monitoring.
22-Nov-2012 - Johnson Matthey saw an uptick in its API business thanks to demand for “higher margin” products.
22-Nov-2012 - Brazilian drug regulator Anvisa wants to engage with the pharmaceutical industry on the disposal of unused drugs.
21-Nov-2012 - BASF has made a bid for Pronova Biopharma ASA, underlining its intention to become the dominant player in the pharmaceutical grade omega-3 API market.
21-Nov-2012 - US insurers will cover more medicines under Obamacare according to a document published by the Department of Health and Human Services (DHSS) in the Federal Register earlier this week.
21-Nov-2012 - Fujifilm has developed a new “pain-free” alternative to hypodermic needles which delivers drugs through a sheet of material covered in tiny dissolvable needles.
21-Nov-2012 - Improper antibiotic use is driving the ‘Superbug’ epidemic but irresponsible promotional may be exacerbating the problem according to the WHO.
20-Nov-2012 - The US FDA has finally adopted the revised ICH Q11 guidelines on drug substance manufacturing nearly six months after European regulators embraced the guidelines.
|« Previous month||Next month »|